항산균 배양 기기 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 검사 유형별, 기술별, 최종사용자별, 용도별, 지역별 - 업계 예측(2026-2033년)

Global Mycobacteria Culture Devices Market size was valued at USD 842.0 Million in 2024 and is poised to grow from USD 908.52 Million in 2025 to USD 1669.19 Million by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The growing emphasis on monitoring antimicrobial resistance is propelling the market for mycobacteria culture devices, as health authorities seek advanced platforms to confirm the phenotypic susceptibility of mycobacterial isolates. Companies that offer solutions integrating imaging with AI-driven analytics are enhancing laboratory efficiency by minimizing manual processes and expediting reporting, ultimately improving patient outcomes and reducing transmission risks. For instance, an automated MGIT system, when coupled with an analytics portal, has proven effective in optimizing turnaround times, thus attracting funding opportunities and showcasing profitability for manufacturers. This trend paves the way for expanding service contracts, enabling geographic growth in resource-limited areas globally, and fostering collaborations with diagnostic test developers to enhance overall diagnostic capabilities in the mycobacterial segment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycobacteria Culture Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycobacteria Culture Devices Market Segments Analysis

Global mycobacteria culture devices market is segmented by product type, test type, technology, end user, application and region. Based on product type, the market is segmented into Automated Culture Systems, Manual Culture Systems, Culture Media and Consumables & Accessories. Based on test type, the market is segmented into Tuberculosis (TB) and Non-Tuberculous Mycobacteria (NTM). Based on technology, the market is segmented into Liquid Culture and Solid Culture. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Research & Academic Institutes and Public Health Laboratories. Based on application, the market is segmented into Clinical Diagnostics, Drug Susceptibility Testing and Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mycobacteria Culture Devices Market

The demand for faster identification of mycobacterial infections among healthcare providers is driving the need for advanced culture devices in laboratories. These innovative devices significantly reduce incubation times, enhance detection accuracy, and streamline workflow processes, thereby allowing clinicians to make better-informed therapeutic decisions. This, in turn, improves patient outcomes and reduces the risk of disease transmission. As the need for efficient culture technologies grows, manufacturers are responding by broadening their product offerings and investing in research and development. This cycle of increased adoption and awareness of diagnostic benefits is propelling the overall growth of the global mycobacteria culture devices market.

Restraints in the Global Mycobacteria Culture Devices Market

The high acquisition costs associated with advanced mycobacterial culture devices present a significant challenge, particularly for smaller hospitals and laboratories with constrained budgets. These institutions are compelled to focus on essential equipment, frequently postponing investment in higher-end culture technologies in favor of more affordable, albeit less efficient, options. As a result, price-sensitive segments of the market experience slower adoption rates, hindering overall growth prospects until there are more accessible financing options or reductions in device costs. Additionally, lengthy regulatory approval processes can delay the realization of return on investment, further complicating expansion efforts in this market segment.

Market Trends of the Global Mycobacteria Culture Devices Market

The Global Mycobacteria Culture Devices market is witnessing a significant trend toward the adoption of Point-of-Care culture systems. Healthcare providers are increasingly demanding decentralized testing solutions that facilitate the rapid analysis of mycobacterial infections directly at or near the patient's location. These innovative devices are designed with compact footprints and user-friendly interfaces, making them suitable for outpatient clinics, remote hospitals, and field settings. By minimizing reliance on centralized laboratories, they not only reduce sample transport delays but also enhance infection control monitoring. Manufacturers are prioritizing rugged designs and battery-operated functionalities, positioning these systems as vital tools for improving diagnostic capabilities in underserved areas globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Mycobacteria Culture Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Automated Culture Systems
• Manual Culture Systems
• Culture Media
• Consumables & Accessories

Global Mycobacteria Culture Devices Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Tuberculosis (TB)
• Non-Tuberculous Mycobacteria (NTM)

Global Mycobacteria Culture Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Liquid Culture
• Solid Culture

Global Mycobacteria Culture Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research & Academic Institutes
• Public Health Laboratories

Global Mycobacteria Culture Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics
• Drug Susceptibility Testing
• Research

Global Mycobacteria Culture Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Test Type, Technology, End User, Application)
  • US
  • Canada
• Europe (Product Type, Test Type, Technology, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, Technology, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, Technology, End User, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, Technology, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hardy Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Titan Biotech Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Liofilchem S.r.l.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeptoMetrix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microbiologics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COPAN Italia S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations